These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Tolbutamide in diabetes; some clinical and biochemical studies. CROWLEY MF; WOLFF FW; BLOOM A Br Med J; 1957 Aug; 2(5040):327-31. PubMed ID: 13446470 [No Abstract] [Full Text] [Related]
24. Clinical experience and experimental studies with tolbutamide. CRAIG JW; MILLER M Diabetes; 1957; 6(3):280-2; discussion, 282-9. PubMed ID: 13427636 [No Abstract] [Full Text] [Related]
25. Insulin adjuvants or substitutes. BEST CH Can Med Assoc J; 1956 Jun; 74(12):957-9. PubMed ID: 13329940 [No Abstract] [Full Text] [Related]
26. [New substances with effect on blood sugar]. ZAWACKI F; JUNG F Klin Wochenschr; 1957 Apr; 35(7):363-4. PubMed ID: 13429840 [No Abstract] [Full Text] [Related]
27. Hypoglycemic sulfonylureas in various types of experimental diabetes. BUSE JF; GORDON MF; LUKENS FD Diabetes; 1957; 6(1):7-12; discussion, 19-20. PubMed ID: 13397410 [No Abstract] [Full Text] [Related]
28. [Therapy of sulfanilamide-resistant diseases with mixtures of sulfanilamide compounds with urea]. JUDELES AL; POSTOVSKY IJ Klin Med (Mosk); 1947; 25(1):65-9. PubMed ID: 20269445 [No Abstract] [Full Text] [Related]
29. Sulfonylureas and diabetes mellitus. II. Preliminary studies of the mechanism of action. COX RW; HENLEY ED; WILLIAMS RH Diabetes; 1956; 5(5):366-77. PubMed ID: 13365476 [No Abstract] [Full Text] [Related]
30. Present state of knowledge concerning effects of the sulfonylurea compounds in diabetes mellitus; report of the Committee on Summarization of the Conference. KRAHL ME; LUKENS FD; RICKETTS HT Diabetes; 1957; 6(1):91-2. PubMed ID: 13397436 [No Abstract] [Full Text] [Related]
32. Studies on the mechanism of action of orinase (tolbutamide). VAUGHAN M Diabetes; 1957; 6(1):16-8; discussion, 19-20. PubMed ID: 13397412 [No Abstract] [Full Text] [Related]
34. Observations on the action of tolbutamide. ANDERSON GE; MONACO RN; PERFETTO AJ; TERMINE CM Diabetes; 1957; 6(1):34-40; discussion, 43-5. PubMed ID: 13397419 [No Abstract] [Full Text] [Related]
35. Studies of the mechanism of action of sulfonylurea derivatives. GOLDNER MG; LAZARUS SS; VOLK BW; WEISENFELD S Diabetes; 1957; 6(1):53-4. PubMed ID: 13397423 [No Abstract] [Full Text] [Related]
36. Sulfonylureas and diabetes mellitus. I. Clinical evaluation. COX RW; FERGUS EB; HENLEY ED; WILLIAMS RH Diabetes; 1956; 5(5):358-65. PubMed ID: 13365475 [No Abstract] [Full Text] [Related]
37. The site of action of the arylsulfonylureas in man. FROESCH ER; RENOLD AE; THORN GW; WINEGRAD AI Diabetes; 1957; 6(1):33; discussion, 43-5. PubMed ID: 13397418 [No Abstract] [Full Text] [Related]